StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MBIO

Mustang Bio, Inc.

MBIO Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.58
+0.01 +1.16%

Key statistics

from XBRL data in SEC filings
Market cap
$3.88M
Revenue (TTM)
$0.00
Net income (TTM)
-$2.72M
EPS (TTM)
$-0.48
P/E ratio
Dividend yield
Free cash flow
Cash
$16.3M
Total assets
$16.6M
Gross margin
52-week range
$0.53 – $1.88

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Delisting notice or listing-rule failure Apr 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Shareholder vote results; Other events Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Other events Jul 9, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Other events Mar 5, 2025 8-K Completed an acquisition or disposition; Other events Feb 27, 2025 8-K Shareholder vote results Feb 21, 2025 8-K Entered a material agreement; Terminated a material agreement Feb 13, 2025 8-K Entered a material agreement; Other events Feb 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jan 17, 2025 8-K Shareholder vote results Jan 10, 2025 8-K Shareholder vote results Jan 2, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Item 5.08; Other events Nov 6, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Oct 25, 2024 8-K Delisting notice or listing-rule failure Sep 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Shareholder vote results Jul 3, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 24, 2024 8-K Entered a material agreement; Terminated a material agreement Jun 6, 2024 8-K Delisting notice or listing-rule failure; Other events May 21, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement; Other events May 2, 2024 8-K Results of operations (earnings release) Apr 29, 2024 8-K Exit or disposal costs Apr 12, 2024 8-K Other events Mar 29, 2024 8-K Delisting notice or listing-rule failure Mar 15, 2024 8-K Results of operations (earnings release) Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Other events Feb 14, 2024 8-K Director or officer change Jan 25, 2024 8-K Other events Jan 4, 2024 8-K Director or officer change Dec 12, 2023 8-K Other events Dec 11, 2023